Vaxcyte Net Invested Capital from 2010 to 2025

PCVX Stock  USD 70.70  2.14  3.12%   
Vaxcyte Net Invested Capital yearly trend continues to be fairly stable with very little volatility. Net Invested Capital is likely to outpace its year average in 2025. Net Invested Capital is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. View All Fundamentals
 
Net Invested Capital  
First Reported
2020-03-31
Previous Quarter
3.4 B
Current Value
3.3 B
Quarterly Volatility
989.5 M
 
Covid
Check Vaxcyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Vaxcyte's main balance sheet or income statement drivers, such as Interest Income of 115.5 M, Interest Expense of 0.0 or Selling General Administrative of 97.5 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 1.82. Vaxcyte financial statements analysis is a perfect complement when working with Vaxcyte Valuation or Volatility modules.
  
Check out the analysis of Vaxcyte Correlation against competitors.
For more information on how to buy Vaxcyte Stock please use our How to Invest in Vaxcyte guide.

Latest Vaxcyte's Net Invested Capital Growth Pattern

Below is the plot of the Net Invested Capital of Vaxcyte over the last few years. It is the total amount of capital invested in a company, including both equity and debt, minus any cash or cash equivalents. Vaxcyte's Net Invested Capital historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Vaxcyte's overall financial position and show how it may be relating to other accounts over time.
Net Invested Capital10 Years Trend
Slightly volatile
   Net Invested Capital   
       Timeline  

Vaxcyte Net Invested Capital Regression Statistics

Arithmetic Mean560,934,122
Geometric Mean177,936,483
Coefficient Of Variation209.08
Mean Deviation840,909,183
Median(57,728,000)
Standard Deviation1,172,814,570
Sample Variance1375494T
Range3.6B
R-Value0.74
Mean Square Error662202.4T
R-Squared0.55
Significance0.001
Slope182,801,540
Total Sum of Squares20632410.3T

Vaxcyte Net Invested Capital History

20253.5 B
20243.3 B
20231.2 B
2022953.6 M
2021284 M
2020345.8 M
2019-106.4 M

About Vaxcyte Financial Statements

Vaxcyte investors use historical fundamental indicators, such as Vaxcyte's Net Invested Capital, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Vaxcyte. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Net Invested Capital3.3 B3.5 B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Vaxcyte Stock Analysis

When running Vaxcyte's price analysis, check to measure Vaxcyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxcyte is operating at the current time. Most of Vaxcyte's value examination focuses on studying past and present price action to predict the probability of Vaxcyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxcyte's price. Additionally, you may evaluate how the addition of Vaxcyte to your portfolios can decrease your overall portfolio volatility.